Related Experiment Video
Updated: May 28, 2026

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
Published on: May 18, 2018
Cells with dendritic cell morphology and immunophenotype, binuclear morphology, and immunosuppressive function in
Rong Dong1, Dale Moulding, Nourredine Himoudi
1Unit of Molecular Haematology and Cancer Biology, UCL Institute of Child Health, London, UK.
Insights
Binuclear cells in dendritic cell (DC) cultures, termed BNiDCs, arise from cell fusion events. These cells exhibit tolerogenic properties, potentially impacting clinical vaccine development.
Area of Science:
- Immunology
- Cell Biology
Background:
- Dendritic cells (DCs) are generated from CD14 positive monocytes for research and clinical vaccines.
- Binuclear cells (BNiDCs) with typical DC morphology were unexpectedly observed in human DC cultures.
Purpose of the Study:
- To investigate the origin and functional characteristics of binuclear cells (BNiDCs) in human dendritic cell cultures.
- To determine the impact of BNiDCs on immune responses and their role in clinical applications.
Main Methods:
- Single cell PCR analysis of mitochondrial DNA polymorphisms to detect cell fusion.
- Flow cytometry to analyze immunophenotype (HLA-DR, IL-12p70, IL-10).
- Mixed lymphocyte reactions (MLRs) to assess BNiDC function.
- Inhibition of dendritic cell-specific transmembrane protein (DC-STAMP) to study BNiDC formation.
Main Results:
- Approximately 20-25% of cells in DC cultures undergo fusion, resulting in BNiDCs.
- BNiDCs express low HLA-DR and IL-12p70, but high IL-10 levels.
- Purified BNiDCs suppressed lymphocyte proliferation in MLRs.
- Blocking DC-STAMP reduced the incidence of BNiDCs.
Conclusions:
- BNiDCs are a fusion-derived population within human DC cultures.
- BNiDCs possess tolerogenic properties, characterized by IL-10 production and suppression of lymphocyte proliferation.
- The formation of BNiDCs can be influenced by DC-STAMP.
- BNiDCs may represent a significant tolerogenic cell population in clinical DC preparations.
Abstract:
Culturing of human peripheral blood CD14 positive monocytes is a method for generation of dendritic cells (DCs) for experimental purposes or for use in clinical grade vaccines. When culturing human DCs in this manner for clinical vaccine production, we noticed that 5-10% of cells within the bulk culture were binuclear or multiple nuclear, but had typical dendritic cell morphology and immunophenotype. We refer to the cells as binuclear cells in dendritic cell cultures (BNiDCs). By using single cell PCR analysis of mitochondrial DNA polymorphisms we demonstrated that approximately 20-25% of cells in DC culture undergo a fusion event. Flow sorted BNiDC express low HLA-DR and IL-12p70, but high levels of IL-10. In mixed lymphocyte reactions, purified BNiDC suppressed lymphocyte proliferation. Blockade of dendritic cell-specific transmembrane protein (DC-STAMP) decreased the number of binuclear cells in DC cultures. BNiDC represent a potentially tolerogenic population within DC preparations for clinical use.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

